BTCI enhances guanylin-induced natriuresis and promotes renal glomerular and tubular effects

Brazilian Journal of Biology

Volumn 68, Issue 1, 2008, Pages 149-154

  Carvalho, A F ^a   Santos Neto, ^a   Monteiro, H S A ^a   Freitas, S M ^b   Morhy, L ^b   Nascimento, N R F ^a   Fonteles, M C ^c  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b UNIVERSITY OF BRASILIA   (Brazil)

^c MACKENZIE PRESBYTERIAN UNIVERSITY   (Brazil)

Author keywords

Bowman Birk protease inhibitors; BTCI; Cyclic GMP; Kidney; Natriuresis; Vignia unguiculata

Indexed keywords

GASTROINTESTINAL HORMONE; GUANYLIN; NATRIURETIC FACTOR; PROTEINASE INHIBITOR; TRYPSIN, CHYMOTRYPSIN INHIBITOR, BLACK EYED PEA; TRYPSIN, CHYMOTRYPSIN INHIBITOR, BLACK-EYED PEA; VEGETABLE PROTEIN;

ANIMAL; ARTICLE; DOSE RESPONSE; DRUG EFFECT; FEMALE; GLOMERULUS; KIDNEY TUBULE; MALE; NATRIURESIS; PHYSIOLOGY; RAT; WISTAR KYOTO RAT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GASTROINTESTINAL HORMONES; KIDNEY GLOMERULUS; KIDNEY TUBULES; MALE; NATRIURESIS; NATRIURETIC PEPTIDES; PLANT PROTEINS; PROTEASE INHIBITORS; RATS; RATS, INBRED WKY;

ENA; PISUM SATIVUM; RATTUS;

EID: 43649086288     PISSN: 15196984     EISSN: 16784375     Source Type: Journal    
DOI: 10.1590/S1519-69842008000100021     Document Type: Article

References (29)

1. CARPICK, BW. and GARIEPY, J., 1993. The Escherichia coli heat-stable enterotoxin is a long-lived superagonist of guanylin. Infect Immun., vol. 61, no. 11, p. 4710-4715.
2. CARRITHERS, SL., TAYLOR, B., CAI, WY., JOHNSON, BR., OTTO, CE., GREENBERG, RN. and JACKSON, BA., 2000. Guanylyl cyclase-C receptor mRNA distribution along the rat nephron. Regul Pep, vol. 95 no. 1-3, p. 65-74.
3. CURRIE, MG., FORK, KF., KATO, J., MOORE, RJ., HAMRA, FK., DUFFIN, KL. and SMITH, CE., 1992. Guanylin: an endogenous activator of intestinal guanylate cylase. Proceedings of the Natl. Acad. Sci. USA, vol. 89 no. 3, p. 947-51.
4. DATE, Y., NAKAZATO, M., YAMAGUCHI, H., MIYAZATO, M., MATSUKURA, S., 1996. Tissue distribution and plasma concentration of human guanylin. Intern Med., vol. 35, no. 3, p. 171-5.
5. FONTELES, MC., COHEN, JJ., BLACK, JJ, and WERTHEIM, SJ,, 1983. Support of kidney function by long-chain fatty acids derived from renal tissue. Am J Physiol, vol. 224, no. 3, p. 235-46.
6. FONTELES, MC., GREENBERG, RN., MONTEIRO, HSA., CURRIE, MG. and FORTE, LR., 1998. Natriuretic and kaliuretic activities of guanylin and uroguanylin in the isolated perfused rat kidney. Am J Physiol, vol. 275 no. 2, pt. 2, p. 191-97.
7. FORTE, LR., KRAUSE, WJ. and FREEMAN RH., 1989. Eschericha coli heat-stable enterotoxin receptors: localization in opossum kidney, intestine and testis. Am J Physiol, vol. 257, no. 5, pt. 2, p. 874-81.
8. FORTE, LR., LONDON, RM., KRAUSE, WJ. and FREEMAN RH., 2000. Mechanism of guanylin action via cyclic GMP in the kidney. Annu Rev Physiol, vol. 62, p. 673-95. Review.
9. FREITAS, SM., MELLO, LV., SILVA, MCM., VRIEND, G., NESHICH, G. and VENTURA, MM., 1997. Analysis of the black-eyed pea trypsin and chymotrypsin inhibitor-∞-chymotrypsin complex. FEBS Lett, vol. 409, no. 2, p. 121-27.
10. GREENBERG, RN., HILL, M., CRYTZER, J., KRAUSE, WJ., EBER, SL., HAMRA, FK. and FORTE, LR., 1997. Comparison of effects of uroguanylin, guanylin and Eschericha coli enterotoxin STA On mouse intestine and kidney: evidence that uroguanylin is an intestinal natriuretic hormone. J Invest Med, vol. 45, no. 5, p. 276-82.
11. HAMRA, FK., FAN, X., KRAUSE, WJ., FREEMAN, RH., CHIN, DT., SMITH, CE., CURRIE, MG. and FORTE, LR., 1996a. Prouroguanylin and proguanylin: purification from colon, structure, and modulation of bioactivity by proteases. Endocrinology., vol. 137, no. 1, p. 257-65.
12. HAMRA, FK., FORTE, LR., EBER, SL., PIDHORODDECKYJ, NV., KRAUSE, WJ., FREEMAN, RH., CHIN, DT., TOMPKINS, JA., FOK, KF., SMITH, CE., DUFFIN KL., SIEGEL, NR. and CURRIE MG, 1993. Uroguanylin: structure and activity of a second endogenous peptide that stimulates intestinal guanylate cyclase. Proc Nat Acad Sci USA, vol. 90, n. 22, p. 10464-8.
13. HAMRA, FK., KRAUSE, WJ., EBER, SL., FREEMAN, RH., SMITH, CE., CURRIE, MG. and FORTE, LR., 1996b. Opossum colonic mucosa contains uroguanylin and guanylin peptides. Am J Physiol., vol. 270, no. 4 pt. 1, G708-16.
14. HUGHES, JM., MURAD, F., CHANG, B. and GUERRANT, RL., 1978. Role of cyclic GMP in the action of heat-stable enterotoxin of Eschericha coli. Nat (London), vol. 271, no. 5647, p. 755-56.
15. KITA, T., SMITH, CE., FOK, KF., DUFFIN, KL., MOORE, WM., KARABATSOS, PJ., KACHUR, JF., HAMRA, FK., PIDHORODECKYJ, NV., FORTE, LR. and CURRIE, MG., 1994. Characterization of human uroguanylin: a member of the guanylin peptide family. Am J Physiol., vol. 266, no. 2, pt 2, p. 342-8.
16. KUHN, M., RAIDA, M., ADERMANN, K., SCHULZ-KNAPPE, P., GERZER, R., HEIM, JM. and FORSSMANN, WG., 1993. The circulating bioactive form of human guanylin is a high molecular weight peptide (10.3 kDa). FEBS Lett., vol. 318, no. 2, p. 205-259.
17. LIMA, AAM., MONTEIRO, HSA. and FONTELES, MC., 1992. The effects of Eschericha coli heat-stable enterotoxin in renal sodium tubular transport. Pharmacol Toxicol, vol. 70, no. 3, p. 163-67.
18. LONDON, RM., EBER, SL., VISWESWARIAH, SS., KRAUSE, WJ. and FORTE, LR., 1999. Structure and activity of OK-GC: kidney receptor activated by guanylin peptides. Am J Physiol, vol. 276, no. 6 pt. 2, p. 882-91.
19. MARTINEZ-MALDONADO, M. and OPAVA-STITZER S., 1978. Free water clearance curves during saline, manitol, glucose and urea diuresis in rats. J Physiol, vol. 280, no. 487-97.
20. MORHY, L. and VENTURA, MM., 1987. The complete amino acid sequence of the Vigna unguiculata (L.) Walp. Seed trypsin and chymotrypsin inhibitor. An Acad Bras Ciênc, vol. 59, no. 1-2, p. 71-81.
21. NAKAZATO, M. YAMAGUCHI, H., KINOSHITA, H., KANGAWA, K., MATSUO, H., CHINO, N. and MATSUKURA, S., 1996. Identification of biologically active and inactive human uroguanylins in plasma and urine and their increases in renal insufficiency. Bioch Bioph Res Co, vol. 220, no. 3, p. 586-93.
22. NAKAZATO, M., YAMAGUCHI, H., SHIOMI, K., DATE, Y., FUJIMOTO, S., KANGAWA, K., MATSUO, H. and MATSUKURA, S., 1994. Identification of 10-kDa proguanylin as a major guanylin molecule in human intestine and plasma and its increase in renal insufficiency. Biochem Biophys Res Commun., 30; vol. 205, no. 3, p. 1966-75.
23. POTTHAST, R., EHLER, R., SCHEVING, LA., SINDIC, A., SCHLATTER, E. and KUHN, M., 2001, High salt intake increase uroguanylin expression in mouse kidney. Endocrinology, vol. 142, no. 7, p. 3087-97.
24. RABKIN, R. and KITAJI, J., 1983. Renal metabolism of peptide hormones. Miner Electrol Metab, vol. 9, no. 4-6, p. 212-26.
25. SANTOS-NETO, MS., CARRITHERS, SL., CARVALHO, AF., MONTEIRO, HS., GREENBERG, RN., FORTE, LR. and FONTELES, MC., 2003. Guanylin and its lysine-containing analogue in the isolated perfused rat kidney: interaction with chymotrypsin inhibitor. Pharmacol Toxicol, vol. 92, no. 3, p. 114-20.
26. SCHULZ, S., CHRISMAN, TD., GARBERS, DL.,1992. Cloning and expression of guanylin. Its existence in various mammalian tissues. J Biol Chem, vol. 267, no. 23, p. 16019-21.
27. SCHULZ, S., CHRISTMAN, TD., YUEN, PST. and GARBERS, DL., 1990. Guanylyl cyclase is a heat-stable enterotoxin receptor. Cell, vol. 63, no. 5, p. 941-48.
28. VENTURA, MM. and XAVIER-FILHO, J., 1966, A trypsin and chymotrypsin inhibitor from black-eyed pea (V. Sinensis L.) I. Purication and partial characterization. An Acad Bras Ciênc, vol. 38 p. 553-66.
29. WALSER, M., DAVIDSON, DG. and ORLOFF, J., 1955. The renal clearance of alkalistable inulin. J Clin Invest, vol. 34, no. 10, p. 1520-23.